Concepedia
Statistics
Publications
20
Citations
1.3K
H-Index
16
Active since
1973
Affiliations
AstraZeneca (France)(Current)
AstraZeneca (United Kingdom)
Chimie ParisTech
Centre National de la Recherche Scientifique
Sorbonne Université
Frédéric Jung is an author at AstraZeneca (France) specializing in medicinal chemistry, drug discovery, and pharmacy.
Publications per year
1973–2011
AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis
Robert W. Wilkinson, Rajesh Odedra, Simon P. Heaton et al. · Clinical Cancer Research · 2007 · 357 citations · Full text
Medicine, Oncology, Pharmacology +16
Discovery, Synthesis, and <i>in Vivo</i> Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase
Andrew Mortlock, Kevin M. Foote, Nicola M. Heron et al. · Journal of Medicinal Chemistry · 2007 · 274 citations · Full text
Medicine, Oncology, Pharmacology +13
SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors
Nicola M. Heron, Malcolm Anderson, David P. Blowers et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 125 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +16
Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors
Frédéric Jung, Georges Pasquet, Christine Lambert‐van der Brempt et al. · Journal of Medicinal Chemistry · 2006 · 92 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Decomposition of 3,6-dihydro-1,2-oxathiin 2-oxides to sulfur dioxide and 1,3-dienes. A .pi.4s+.pi.2s cycloreversion
Frédéric Jung, Marta Dal Molin, R. Van der Elzen et al. · Journal of the American Chemical Society · 1974 · 70 citations
Natural Sciences, Chemistry, Analytical Chemistry +9
1–5 of 20